RxFinder.ai

Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide

Biktarvy

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $136.7316
No Shortage Tier 1: 35.9%

Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide blocks HIV replication by inhibiting reverse transcriptase.

vs. brand Biktarvy: Generic saves up to -1267% per unit

Explore in the Ecosystem

rxsaver.aiCompare prices for Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamidedrfinder.aiFind doctors who prescribe Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamiderxnews.aiLatest news about Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.